Sara Lewis, a formulation development specialist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP) credential.
Awarded by the ISPE Professional Certification Commission, the CPIP credential is the first independent, international competency-based certification for pharmaceutical professionals who support product development through manufacturing. It holds those who qualify to a global competency standard through demonstrated education, experience and rigorous examination.
There are only 76 CPIP-credentialed pharmaceutical professionals worldwide. Lewis is the third employee at Metrics to earn it and with it, Metrics now can claim having more CPIP-credentialed employees than any other contract pharmaceutical development and manufacturing organization.
“That fact that Metrics has more CPIP-credentialed scientists than any of our competitors certainly speaks to our company’s ongoing commitment to pharmaceutical leadership, innovation and quality,” said Dr. Brad Gold, vice president of pharmaceutical development. “It also demonstrates that when we say Metrics values scientific excellence, we truly mean it.”
Lewis, who joined Metrics in 2005, served as a supervisor in the microbiology laboratory before recently moving into formulation development. In her current role, Lewis assists in developing novel formulations for solid oral dosages for non-potent and potent products. She provides data and documentation for regulatory filings and helps manufacture batches for stability and clinical trial testing.
She is actively involved with the company’s safety practices and employee wellness efforts, and was instrumental in launching an ongoing online safety awareness campaign. Lewis earned her bachelor’s of science degree in biology from East Carolina University.
Metrics, Inc. (metricsinc.com) is a full-service global pharmaceutical development and manufacturing organization serving clients worldwide. We deliver proven scientific and operational excellence for solid oral dosage forms.
Our company’s areas of expertise include quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical trial materials (CTM) manufacturing for Phase I, II and III trials; and analytical method development and validation services leading to commercial scale manufacturing.
Metrics’ capabilities include highly potent, cytotoxic and unstable compounds, Schedule II-V controlled substances, and products with poor bioequivalence for which we offer an impressive portfolio of advanced delivery methods. Based in Greenville, N.C., Metrics proudly operates as a subsidiary of Mayne Pharma Group Limited.